Literature DB >> 2494631

Src homology 2 domain deletion mutants of p60v-src do not phosphorylate cellular proteins of 120-150 kDa.

P A Wendler1, F Boschelli.   

Abstract

We have constructed seven deletions in the src homology 2 (SH2) domain of the Rous sarcoma virus src gene and have expressed them and wild-type v-src (wt v-src) in Rat 1 fibroblasts. Transfected cells containing mutant DNAs have reduced focus forming activity when compared to cells containing the wt v-src DNA. In most cases, established cell lines that express these mutants have altered growth properties in soft agar. The src proteins isolated from mutant cell lines have reduced tyrosine kinase activity. We also see differences in the phosphorylation of cellular proteins in vivo. Unlike the wt protein kinase, the SH2 domain mutant kinases do not phosphorylate a set of cellular proteins ranging in size from 120-150 kDa.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2494631

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  Multiple SH2-mediated interactions in v-src-transformed cells.

Authors:  C A Koch; M F Moran; D Anderson; X Q Liu; G Mbamalu; T Pawson
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

2.  A cell-based screen for inhibitors of protein folding and degradation.

Authors:  Frank Boschelli; Jennifer M Golas; Roseann Petersen; Vincent Lau; Lei Chen; Diane Tkach; Qiang Zhao; Dave S Fruhling; Hao Liu; Chaneun Nam; Kim T Arndt
Journal:  Cell Stress Chaperones       Date:  2010-08-19       Impact factor: 3.667

3.  The common src homology region 2 domain of cytoplasmic signaling proteins is a positive effector of v-fps tyrosine kinase function.

Authors:  C A Koch; M Moran; I Sadowski; T Pawson
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

4.  Transformation by pp60src or stimulation of cells with epidermal growth factor induces the stable association of tyrosine-phosphorylated cellular proteins with GTPase-activating protein.

Authors:  A H Bouton; S B Kanner; R R Vines; H C Wang; J B Gibbs; J T Parsons
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

5.  Identification and characterization of a novel cytoskeleton-associated pp60src substrate.

Authors:  H Wu; A B Reynolds; S B Kanner; R R Vines; J T Parsons
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

6.  A glycoprotein in the plasma membrane matrix as a major potential substrate of p60v-src.

Authors:  M Hamaguchi; M Matsuda; H Hanafusa
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

7.  Activation of the proto-oncogene p60c-src by point mutations in the SH2 domain.

Authors:  M C O'Brien; Y Fukui; H Hanafusa
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

8.  CDC37 is required for p60v-src activity in yeast.

Authors:  B Dey; J J Lightbody; F Boschelli
Journal:  Mol Biol Cell       Date:  1996-09       Impact factor: 4.138

9.  Expression of p60v-src in Saccharomyces cerevisiae results in elevation of p34CDC28 kinase activity and release of the dependence of DNA replication on mitosis.

Authors:  F Boschelli
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

10.  Host range mutants of v-src: alterations in kinase activity and substrate interactions.

Authors:  E C Liebl; L J England; J E DeClue; G S Martin
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.